Here’s some of HealthDay’s top stories for Friday, July 9: Pfizer/BioNTech seek approval for COVID booster. The companies behind a successful COVID vaccine say they’re already looking for approval for a booster shot. But the FDA, CDC and many experts say it’s uncertain a third dose will ever be needed.Continue Reading

FRIDAY, July 9, 2021 (HealthDay News) — Why do some people infected with SARS-CoV-2 have either no or negligible symptoms, while others sicken and die? Scientists who’ve pinpointed several genetic markers associated with severe COVID-19 say their findings could provide answers to that important question — and targets for futureContinue Reading

FRIDAY, July 9, 2021 (HealthDay News) — A double dose of China’s CoronaVac vaccine is 83.5% effective against symptomatic COVID-19, researchers say. Their phase 3 trial included more than 10,000 people, aged 18 to 59, in Turkey who received either two doses of CoronaVac 14 days apart or an inactiveContinue Reading

THURSDAY, July 8, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Thursday issued new prescribing rules for the controversial Alzheimer’s medication Aduhelm that will likely limit its use. When first approved a month ago, the FDA said Biogen’s monthly IV drug was for all Alzheimer’s patients. TheContinue Reading